166 related articles for article (PubMed ID: 10667678)
1. Metaphyseal undertubulation in gaucher disease: resolution at MRI in a patient undergoing enzyme replacement therapy.
Kelman CG; Disler DG
J Comput Assist Tomogr; 2000; 24(1):173-5. PubMed ID: 10667678
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow relaxation times in Gaucher disease before and after enzyme replacement therapy.
Magnaldi S; Longo R; Ukmar M; Zanatta M; Bottega M; Sottocasa GL
Eur Radiol; 1997; 7(4):486-91. PubMed ID: 9204325
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
[TBL] [Abstract][Full Text] [Related]
4. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score.
Robertson PL; Maas M; Goldblatt J
AJR Am J Roentgenol; 2007 Jun; 188(6):1521-8. PubMed ID: 17515371
[TBL] [Abstract][Full Text] [Related]
5. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
6. Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement.
Hermann G; Pastores GM; Abdelwahab IF; Lorberboym AM
Skeletal Radiol; 1997 Dec; 26(12):687-96. PubMed ID: 9453101
[TBL] [Abstract][Full Text] [Related]
7. Reconversion of bone marrow in Gaucher disease treated with enzyme therapy documented by MR.
Allison JW; James CA; Arnold GL; Stine KC; Becton DL; Bell JM
Pediatr Radiol; 1998 Apr; 28(4):237-40. PubMed ID: 9545478
[TBL] [Abstract][Full Text] [Related]
8. [Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement].
Poll LW; vom Dahl S; Koch JA; Börner D; Willers R; Cohnen M; Jung G; Scherer A; Niederau C; Häussinger D; Mödder U
Rofo; 2001 Oct; 173(10):931-7. PubMed ID: 11588682
[TBL] [Abstract][Full Text] [Related]
9. MRI of multiple platyspondyly in Gaucher disease: response to enzyme replacement therapy.
Hill SC; Parker CC; Brady RO; Barton NW
J Comput Assist Tomogr; 1993; 17(5):806-9. PubMed ID: 8370839
[TBL] [Abstract][Full Text] [Related]
10. Initiation of enzyme replacement therapy for an adult patient with asymptomatic type 1 Gaucher's disease.
Tanaka N; Saito H; Ito T; Momose K; Ishida F; Hora K; Kiyosawa K; Ida H
Intern Med; 2001 Aug; 40(8):716-21. PubMed ID: 11518109
[TBL] [Abstract][Full Text] [Related]
11. [Bone involvement during revealed late Gaucher's disease].
Frikha F; Marzouk S; Kaddour N; Frigui M; Mseddi S; Boudawara T; Bahloul Z
Presse Med; 2009 Apr; 38(4):677-81. PubMed ID: 18829247
[No Abstract] [Full Text] [Related]
12. Retrospective Analysis of Whole-Body Magnetic Resonance Imaging of Bone Manifestations in Long-Term Treated Patients with Gaucher Disease Type 1.
Lollert A; Laudemann K; Mengel E; Hoffmann C; Moos L; Reinke J; Brixius-Huth M; Hennermann JB; Düber C; Staatz G
Klin Padiatr; 2019 Mar; 231(2):52-59. PubMed ID: 30481833
[TBL] [Abstract][Full Text] [Related]
13. Clinical Utility of Bone Marrow Study in Gaucher Disease: A Case Report of Gaucher Disease Type 3 With Intractable Myoclonic Seizures.
Rim JH; Baik M; Yoon SO; Heo K; Song J
Ann Lab Med; 2016 Mar; 36(2):177-9. PubMed ID: 26709268
[No Abstract] [Full Text] [Related]
14. Regression of skeletal changes in type 1 Gaucher disease with enzyme replacement therapy.
Pastores GM; Hermann G; Norton KI; Lorberboym M; Desnick RJ
Skeletal Radiol; 1996 Jul; 25(5):485-8. PubMed ID: 8837283
[TBL] [Abstract][Full Text] [Related]
15. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
[TBL] [Abstract][Full Text] [Related]
16. [MRI bone marrow findings in 63 patients with type I Gaucher disease].
Poll LW; Willers R; Häussinger D; Mödder U; vom Dahl S
Rofo; 2010 Nov; 182(11):979-85. PubMed ID: 20509100
[TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.
Rosenthal DI; Doppelt SH; Mankin HJ; Dambrosia JM; Xavier RJ; McKusick KA; Rosen BR; Baker J; Niklason LT; Hill SC
Pediatrics; 1995 Oct; 96(4 Pt 1):629-37. PubMed ID: 7567322
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results.
Poll LW; Koch JA; vom Dahl S; Willers R; Scherer A; Boerner D; Niederau C; Häussinger D; Mödder U
Skeletal Radiol; 2001 Sep; 30(9):496-503. PubMed ID: 11587517
[TBL] [Abstract][Full Text] [Related]
19. Low-dose versus high-dose therapy for Gaucher disease: Goals and markers.
Hollak CE; de Fost M; Aerts JM; vom Dahl S
Blood; 2007 Jan; 109(1):387; author reply 387-8. PubMed ID: 17190857
[No Abstract] [Full Text] [Related]
20. Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.
Charrow J; Andersson HC; Kaplan P; Kolodny EH; Mistry P; Pastores G; Prakash-Cheng A; Rosenbloom BE; Scott CR; Wappner RS; Weinreb NJ
J Pediatr; 2004 Jan; 144(1):112-20. PubMed ID: 14722528
[No Abstract] [Full Text] [Related]
[Next] [New Search]
